In the year 2000, one child out of 150 children born was diagnosed with autism. Today, one out of 68 children will now be affected by it. As the number of children born with autism increases each year, doctors are attempting to treat the condition by testing children as early as three or four years old.
Early signs of autism in babies, such as not responding to their names by one year of age or not showing any interest in objects by 14 months, can be an indicator that therapy may be needed to prevent further advancement of the condition. Some families have a relatively low risk of having a child born with autism, while other families are more likely to have a child who has the condition if they have a family history of autism.
Dr. Jonathan Green and his team at the University of Manchester in the UK are now studying the effects of an adapted Video Interaction for Promoting Positive Parenting Program (i-BASIS-VIPP), a new treatment for early onset autism in infants. The treatment uses video feedback that allows parents to learn how to communicate with their child’s unique communication style. Over time, this could help the child develop stronger communication and social skills.
With the help of a therapist, video recordings of parent-infant interactions are done privately in the parents’ home. When reviewing the recordings, parents can view how they can improve their interactions with their infant. The study used 54 families who had an infant between seven to 10 months old. During a five month period, some families used i-BASIS-VIPP treatment, while the other families received no treatment.
At the end of the experiment, the Autism Observation Scale for Infants (AOSI) was used to determine autism scores of the infants in the study. The infants of the families who used the new treatment showed improved attention and social behavior and had lower AOSI scores than the children who received no treatment at all.
Although the study has not yet proven to eliminate autism in babies, it is a stepping stone for more research that will reveal more about the effects of i-BASIS-VIPP and its possibilities of reducing early autism symptoms.
Mara Papleo, Cleveland State University